#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Squamous cell carcinoma of the cervix Dent's disease Spinal muscular atrophy Haemophilia B without inhibitors Oesophageal achalasia Rheumatoid arthritis Neurofibroma Hepatitis D Congenital generalised lipodystrophy Pyruvate kinase deficiency anaemia Follicular lymphoma stage II Short stature Hyperchylomicronaemia Follicular lymphoma stage I Hypereosinophilic syndrome More trials…

    Learn about Rare Diseases

    Factor IX deficiency – Basic Information Advanced systemic mastocytosis – Basic Information Glycogen storage disease type I – Trials in Disease Ornithine transcarbamoylase deficiency – Trials in Disease Hyperoxaluria Antisynthetase syndrome – Trials in Disease Undifferentiated sarcoma – Life with Disease Glycogen storage disease type II – Treatment Factor IX deficiency Alveolar rhabdomyosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ep0042 Procarbazine Hydrochloride Pemetrexed Diacid Monohydrate Morphine Sulfate NALMEFENE HYDROCHLORIDE Abc-23B-116 Umeclidinium Bromide ANOC-001 Hypromellose ALXN1920 Lazertinib LUNRESERTIB Edoxaban Hct116-A Carboplatin TAZAROTENE Simeticone Vidutolimod Dalbavancin Astegolimab More therapies…

    Learn about Your Condition

    Childhood asthma Strongyloidiasis Testicular germ cell tumour Oesophageal cancer metastatic Peripheral spondyloarthritis Pertussis Round cell liposarcoma Spinal osteoarthritis Drug dependence Adenovirus infection Pharyngeal cancer stage III Urticaria Skin bacterial infection Neuromyopathy Retinal vein occlusion More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Reducing Post-Surgery Complications in Cancer Patients Using Ketorolac, Aspirin, and a Drug Combination

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • KETOROLAC TROMETAMOL
    • Acetylsalicylic Acid
    • Sodium Chloride
    Italy

  • Study on Datopotamab Deruxtecan and Rilvegostomig for Stage I Non-Small Cell Lung Cancer Patients with ctDNA-Positive or High-Risk Features

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage I
    Investigated Drugs:
    • Vinorelbine
    • Carboplatin
    • Cisplatin
    Belgium France Germany Hungary Italy The Netherlands +3

  • Study of Nivolumab and Ipilimumab or Drug Combination for Patients with Metastatic Kidney Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Renal cancer
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    France

  • Evaluation of Methylprednisolone and Prednisone in Adult Patients with Acute Myocarditis and Reduced Heart Function

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Methylprednisolone
    • Prednisone
    France

  • Study on Preoperative Iron Infusion with Ferric Carboxymaltose for Patients with Stomach Cancer

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • Ferric Carboxymaltose
    • Sodium Chloride
    Finland

  • Study on Premedication with Ketamine or Fentanyl for Patients with Respiratory Distress Syndrome Receiving Surfactant Treatment

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute respiratory distress syndrome
    Investigated Drugs:
    • Fentanyl Citrate
    • Esketamine Hydrochloride
    Finland
Previous Page
1 … 816 817 818 819 820 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!